The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Some stimulatory receptors of the innate immune system, such as the NKG2D receptor (also called KLRK1) expressed by natural killer cells and activated CD8(+)T cells, recognize self-molecules that are upregulated in diseased cells by poorly understood mechanisms. Here we show that mouse and human NKG2D ligands are upregulated in non-tumour cell lines by genotoxic stress and stalled DNA replication, conditions known to activate a major DNA damage checkpoint pathway initiated by ATM (ataxia telangiectasia, mutated) or ATR (ATM- and Rad3-related) protein kinases. Ligand upregulation was prevented by pharmacological or genetic inhibition of ATR, ATM or Chk1 (a downstream transducer kinase in the pathway). Furthermore, constitutive ligand expression by a tumour cell line was inhibited by targeting short interfering RNA to ATM, suggesting that ligand expression in established tumour cells, which often harbour genomic irregularities, may be due to chronic activation of the DNA damage response pathway. Thus, the DNA damage response, previously shown to arrest the cell cycle and enhance DNA repair functions, or to trigger apoptosis, may also participate in alerting the immune system to the presence of potentially dangerous cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In addition, genomic damage—a common cause of cellular senescence—induces expression of the membrane-bound ligands for the major natural killer cell receptor NKG2D (140).”
From Aging, Cellular Senescence, and Cancer (2013) · cites this paper as [140]
The cited source says what the claim attributes to it.
In the citing paper
“other evidence indicates that the immune system's recognition of tumour cells might require the continuous activation of the DDR pathway 13”
From The common biology of cancer and ageing (2007) · cites this paper as [13]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Further, DNA damage or activation of oncogenes can induce cellular senescence, through a pathway that relies, in part, on the secretion of pro-inflammatory cytokines such as insulin-like growth factor binding protein-7 (IGFBP7)32 and IL-633, and on the secretion of CXC-chemokine ligand 8 (CXCL8) and other chemokines 33,34, as well as on the expression of the CXCL8 receptor CXC-chemokine receptor 2”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [32]
Experimental — accuracy not yet measuredIn the citing paper
“These findings are consistent with previous studies suggesting that NKG2D ligands are induced by a variety of other stimuli, including E2F transcription factors, PI3 kinase, Ras oncogene signaling, and an activated DNA damage response (Gasser et al., 2005; Tokuyama et al., 2011; Jung et al., 2012).”
From p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells (2013) · cites this paper as Gasser et al., 2005
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: p73α Regulation by Chk1 in Response to DNA Damage
Gonzalez, S., Prives, C., & Cordon-Cardo, C. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.22.8161-8171.2003 · Cited by 75
RetractedDNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation
Bakkenist, C. J., & Kastan, M. B. (2003) · Nature · doi:10.1038/nature01368 · Cited by 3,466
Molecular Mechanisms of Mammalian DNA Repair and the DNA Damage Checkpoints
Sancar, A., Lindsey-Boltz, L. A., Ünsal-Kaçmaz, K., & Linn, S. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.073723 · Cited by 3,317
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
Bartkova, J., Hořejší, Z., Koed, K., Krämer, A., Tort, F., Zieger, K., Guldberg, P., Sehested, M., Nesland, J. M., Lukas, C., et al. (2005) · Nature · doi:10.1038/nature03482 · Cited by 2,688
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions
Gorgoulis, V. G., Vassiliou, L.-V. F., Karakaidos, P., Zacharatos, P., Kotsinas, A., Liloglou, T., Venere, M., DiTullio, R. A., Kastrinakis, N. G., Levy, B., et al. (2005) · Nature · doi:10.1038/nature03485 · Cited by 2,009
Cell cycle checkpoint signaling through the ATM and ATR kinases
Abraham, R. T. (2001) · Genes & Development · doi:10.1101/gad.914401 · Cited by 1,966
Chk1 and Chk2 kinases in checkpoint control and cancer
Bartek, J., & Lukas, J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00110-7 · Cited by 1,513
Roles of the NKG2D immunoreceptor and its ligands
Raulet, D. H. (2003) · Nature Reviews Immunology · doi:10.1038/nri1199 · Cited by 1,348
Self-citation(1999) · PubMed · Cited by 1,030
ATR disruption leads to chromosomal fragmentation and early embryonic lethality
Brown, E. J., & Baltimore, D. (2000) · Genes & Development · doi:10.1101/gad.14.4.397 · Cited by 951
Self-citation
Cited by
Items 901–1,000 of 1,000
Interactions between radiation therapy and immunotherapy: the best of two worlds?
Thamm, D. H. (2006) · Veterinary and Comparative Oncology · doi:10.1111/j.1476-5829.2006.00110.x · Cited by 14
Genome integrity and inflammation in the nervous system
Aditi, A., & McKinnon, P. J. (2022) · DNA repair · doi:10.1016/j.dnarep.2022.103406 · Cited by 14
Gregorie, C. J., Wiesen, J. L., Magner, W. J., Lin, A. W., & Tomasi, T. B. (2009) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2009.02.009 · Cited by 13
“HDACi activation of ATM (ataxia telangiectasia, mutated) (Gasser et al., 2005) likely contributes to a form of senescence similar to that which occurs following DNA damage and oncogene-induced senescence (Bartkova et al.”
BackgroundHu, X., Li, Y., Bian, Y., Zeng, X., Luo, S., Wen, Q., & Chen, P. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.122560 · Cited by 13
The cell stress and immunity cycle in cancer: Toward next generation of cancer immunotherapy
Laureano, R. S., Vanmeerbeek, I., Sprooten, J., Govaerts, J., Naulaerts, S., & Garg, A. D. (2023) · Immunological Reviews · doi:10.1111/imr.13287 · Cited by 13
“25,26 27–29 Binding of NKG2D to its ligands allows the recognition and elimination of the damaged cells, constituting a mechanism of immunosurveillance against premalignant cells and viral infections.”
BackgroundIL-18 enhances ULBP2 expression through the MAPK pathway in leukemia cells
Song, H., KIM, K., Hur, D., Lim, J., Yang, Y. D., Cho, B. J., Kim, C. H., Kim, T. S., Bang, S., Lee, W. J., et al. (2008) · Immunology Letters · doi:10.1016/j.imlet.2008.07.007 · Cited by 13
The Role of Tumor-Derived Vesicles in the Regulation of Antitumor Immunity
Ukrainskaya, V. M., Rubtsov, Y. P., Knorre, V. D., Maschan, M. A., Gabibov, A. G., & Stepanov, A. V. (2019) · Acta Naturae · doi:10.32607/20758251-2019-11-4-33-41 · Cited by 14
Extended loci histocompatibility matching in HSCT—Going beyond classical HLA
Neuchel, C., Furst, D. E., Tsamadou, C., Schrezenmeier, H., & Mytilineos, J. (2021) · International Journal of Immunogenetics · doi:10.1111/iji.12545 · Cited by 14
“MICA is considered as a cell stress marker, as its expression is inducible by heat, viral infection, inflammation and DNA damage (Gasser et al., 2005; Groh et al., 1996, 2001; Schreiner et al., 2006).”
BackgroundFujita, H., Hatanaka, Y., Sutoh, Y., Suzuki, Y., Oba, K., Hatanaka, K. C., Mitsuhashi, T., Otsuka, N., Fugo, K., Kasahara, M., et al. (2014) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155414563800 · Cited by 13
“The cellular expression of these ligands can be upregulated in response to a variety of stimuli, such as viral infection, tissue ischemia, heat shock and malignant transformation (Groh et al. 1996; Gasser et al. 2005; Groh et al. 2001).”
BackgroundCibler les télomères pour forcer les cellules cancéreuses à rentrer en sénescence
Londoño‐Vallejo, A., Lenain, C., & Gilson, É. (2008) · médecine/sciences · doi:10.1051/medsci/2008244383 · Cited by 13
“De manière intéressante, il semble que la réponse au dommage à l’ADN ne conduit pas uniquement à un arrêt du cycle et à un renforcement des fonctions de réparation, mais aussi à la stimulation du système immunitaire inné [33].”
Epidermal γδ T cells sense precancerous cellular dysregulation and initiate immune responses
Shimura, E., Hozumi, N., Kanagawa, O., METZGER, D., Chambon, P., Radtke, F., Hirose, S., & Nakano, N. (2010) · International Immunology · doi:10.1093/intimm/dxq014 · Cited by 13
Natural killer cells blaze into immuno-oncology
Garber, K. (2016) · Nature Biotechnology · doi:10.1038/nbt0316-219 · Cited by 13
APOBEC3 versus Retroviruses, Immunity versus Invasion: Clash of the Titans
Sheehy, A. M., & Erthal, J. (2012) · Molecular Biology International · doi:10.1155/2012/974924 · Cited by 12
“While the relevance of these interesting observations in regard to HIV-1 infection is not immediately obvious (the A3A experiments were performed in human osteosarcoma cells) the role that the DDR response pathway plays in the innate immune response has only recently been explored and appreciated [68, 69].”
BackgroundGuo, Y., Li, Z., Parsels, L. A., Wang, Z., Parsels, J. D., Dalvi, A., The, S., Hu, N., Valvo, V. M., Doherty, R. E., et al. (2025) · Neuro-Oncology · doi:10.1093/neuonc/noaf097 · Cited by 12
Wang, W.-J., Qin, S., Zhang, J., Jiang, Y., Zhang, J.-N., & Zhao, L. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.22.9667 · Cited by 13
“Doxorubicin could be involved in the NK cell-mediated killing of tumor cells by stimulating the expression of the ligands for the NK group 2D (NKG2D) and DNAX accessory molecule-1 (DNAM-1)-activating NK cell receptors (Gasser et al., 2005; Soriani et al., 2009).”
BackgroundAbscopal Effect and Drug-Induced Xenogenization: A Strategic Alliance in Cancer Treatment?
Franzese, O., Torino, F., Giannetti, E., Cioccoloni, G., Aquino, A., Faraoni, I., Fuggetta, M. P., Vecchis, L. D., Giuliani, A., Kaina, B., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910672 · Cited by 13
Mouse genomic associations with in vitro sensitivity to simulated space radiation
Cekanaviciute, E., Tran, D., Nguyen, H., Macha, A. L., Pariset, E., Langley, S. A., Babbi, G., Malkani, S., Penninckx, S., Schisler, J. C., et al. (2022) · Life Sciences in Space Research · doi:10.1016/j.lssr.2022.07.006 · Cited by 14
Xu, Y., Zhang, X., Wang, Y., Pan, M., Wang, M., & Zhang, J. (2019) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-019-02379-9 · Cited by 12
BCL11B regulates MICA/B-mediated immune response by acting as a competitive endogenous RNA
Qian, M., Geng, J., Luo, K., Huang, Z., Zhang, Q., Zhang, J.-A., Ji, L., & Wu, J. (2019) · Oncogene · doi:10.1038/s41388-019-1083-0 · Cited by 13
Lin, F., Dai, C., Ge, X., Tang, W., Lin, Y., Wang, Y., & Li, J. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.04.104 · Cited by 12
MicroRNA-34a promotes MICB expression in hepatocytes
Zhou, M., Zhao, C., Chen, X., Zhang, H., Li, G., Lou, H., Huang, W., Wei, L.-J., Li, D., Wu, X., et al. (2018) · Carcinogenesis · doi:10.1093/carcin/bgy128 · Cited by 12
Han, X., Geng, X., Li, Z., Chen, Z., Liu, Y., Liu, P., Wang, Q., Li, C., Ai, D., & Li, Z. (2018) · World Neurosurgery · doi:10.1016/j.wneu.2018.11.077 · Cited by 12
Role of nano-sensitizers in radiation therapy of metastatic tumors
Thanekar, A. M., Sankaranarayanan, S. A., & Rengan, A. K. (2021) · Cancer Treatment and Research Communications · doi:10.1016/j.ctarc.2021.100303 · Cited by 14
Mei, B., Zhang, S.-R., Chen, Y.-L., & Wang, C. (2012) · Medical Hypotheses · doi:10.1016/j.mehy.2012.06.023 · Cited by 12
“It has been found that activation of DNA damage control pathways results in induction of NKG2D ligands, including ULBPs and possibly MICA [16].”
BackgroundThe dynamics of natural killer cell tolerance
Johansson, M. H., & Höglund, P. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.07.013 · Cited by 14
Characterization of porcine UL16‐binding protein 1 endothelial cell surface expression
Lilienfeld, B. G., Schildknecht, A., Imbach, L., Mueller, N. J., Schneider, M. K. J., & Seebach, J. D. (2008) · Xenotransplantation · doi:10.1111/j.1399-3089.2008.00453.x · Cited by 12
“ionizing radiation and inhibitors of DNA replication via the DNA damage pathway [37], whereas the mechanisms regulating its cell surface expression are largely unknown.”
BackgroundEditorial: Comparative Immunology of Marine Mammals
Guardo, G. D., Criscitiello, M. F., Sierra, E., & Mazzariol, S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02300 · Cited by 13
Immune control in acute myeloid leukemia
Straube, J., Janardhanan, Y., Haldar, R., & Bywater, M. J. (2024) · Experimental Hematology · doi:10.1016/j.exphem.2024.104256 · Cited by 11
The Roles of Natural Killer Cells in Breast Cancer Pathobiology and Their Regulation by Estrogens
Byemerwa, J. K., Chang, C., & McDonnell, D. P. (2025) · Endocrine Reviews · doi:10.1210/endrev/bnaf014 · Cited by 11
Within and beyond the tumor: Mechanisms of glioblastoma-induced immunosuppression
Puviindran, B. J., Wallace, S., Ayasoufi, K., Lerner, E., & Fecci, P. E. (2025) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdaf006 · Cited by 15
“52 The presence of such ligands can mark cells for destruction by NK cells in antigen-independent fashion.”
Immunotherapy of Cancer: Reprogramming Tumor-Immune Crosstalk
Payne, K. K., Toor, A. A., Wang, X., & Manjili, M. H. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/760965 · Cited by 13
“Ionizing irradiation is known to cause cellular stress and enhance the synthesis of a variety of immune-stimulatory and modulating molecules such as heat shock proteins (HSP) [75, 76], high mobility group box 1 (HMGB1) [76], and NKG2D ligands [77].”
BackgroundHoneychurch, J., Melis, M. H. M., Dovedi, S. J., Mu, L., & Illidge, T. (2013) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2013.769219 · Cited by 11
Optimizing Radiotherapy with Immunotherapeutic Approaches
Schoenhals, J. E., Skrepnik, T., Selek, U., Cortez, M. A., Li, A., & Welsh, J. W. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-53156-4_3 · Cited by 11
Dansako, H., Imai, H., Ueda, Y., Satoh, S., Wakita, T., & Kato, N. (2018) · FEBS Open Bio · doi:10.1002/2211-5463.12373 · Cited by 12
IFN-γ Regulates the Expression of MICA in Human Corneal Epithelium Through miRNA4448 and NFκB
Wu, D., Zhang, J., Qian, T., Dai, Y., Mashaghi, A., Xu, J., & Hong, J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01530 · Cited by 12
“DNA damage (28) and the MAPK pathway (29) can regulate MICA gene expression by activating NFκB, indicating that NFκB play a critical role in multiple pathways regulating MICA.”
BackgroundGenotoxic stress signalling as a driver of macrophage diversity
Kasapi, A., & Triantafyllopoulou, A. (2022) · Cell Stress · doi:10.15698/cst2022.03.265 · Cited by 11
“Apoptotic and senescent cells are recognized and removed by phagocytic cells [26]; ATM activation in non-immune cells upregulates natural killer group 2 member D (NKG2D) ligands, activating natural killer (NK) cells at the site of injury [27]; p53 often induces an inflammatory response in the context of tumorigenesis…”
BackgroundImproving Radioresponse Through Modification of the Tumor Immunological Microenvironment
Chi, K., Wang, Y., & Kao, S. (2012) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2011.1048 · Cited by 11
“34 A therapeutic scheme combining the p53 adenovirus and radiotherapy warrants further investigation.”
DNA Repair Gene ZmRAD51A Improves Rice and Arabidopsis Resistance to Disease
Liu, F., Xu, Y., Zhou, L., Ali, A., Jiang, H., Zhu, S., & Li, X. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040807 · Cited by 11
“The abundance of double strand breaks is reduced by plant defense responses, suggesting that the mechanisms for activating DNA repair processes may share some similarity with the induction of PR genes [48,49].”
BackgroundEvaluation of IL-17D in Host Immunity to Group A Streptococcus Infection
Washington, A., Varki, N. M., Valderrama, J. A., Nizet, V., & Bui, J. D. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1901482 · Cited by 11
The dilemma of anticancer therapy: tumor-specific versus immune effects
Zitvogel, L., & Kroemer, G. (2008) · Blood · doi:10.1182/blood-2008-09-176693 · Cited by 11
Dnmt1-dependent Chk1 pathway suppression is protective against neuron division
Oshikawa, M., Okada, K., Tabata, H., Nagata, K., & Ajioka, I. (2017) · Development · doi:10.1242/dev.154013 · Cited by 13
“To generate pCAG-Chk1-HA, pCAG-Dnmt1-HA and pCAG-Cdc25A, the mouse Chk1, Dnmt1, Cdc25A cDNAs were amplified using the Chk1-Fw and Chk1-Rv primers, Dnmt1-Fw and Dnmt1-Rv primers, and Cdc25A-Fw and Cdc25A-Rv primers, respectively, from E16 mouse cerebral cortex cDNA, and the resulting PCR products were inserted into the…”
MethodInfluentialMore damaging than we think: Systemic effects of intestinal inflammation
Westbrook, A. M., Wei, B., Braun, J. G., & Schiestl, R. H. (2009) · Cell Cycle · doi:10.4161/cc.8.16.9274 · Cited by 11
Rendering NK Cells Antigen-Specific for the Therapy of Solid Tumours
Doeppner, C. A., Binder, A. K., Bremm, F., Feuchter, N., Dörrie, J., & Schaft, N. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136290 · Cited by 10
“The ligands of NKG2D are the HLA (human leukocyte antigen) homologues ULBP (UL16-binding proteins) and HLA class I-related molecules (MIC)A/B, which are induced by genotoxic stress or DNA damage [20], oxidative stress [21], and viral infection [22].”
Tanaka, M., Fine, J. H., Kirkham, C. L., Aguilar, O. A., Belcheva, A., Martín, A., Ketela, T. W., Moffat, J., Allan, D., & Carlyle, J. R. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-1688 · Cited by 10
Viral escape from NK‐cell‐mediated immunosurveillance: A lesson for cancer immunotherapy?
Momayyezi, P., Bilev, E., Ljunggren, H., & Hammer, Q. (2023) · European Journal of Immunology · doi:10.1002/eji.202350465 · Cited by 10
“This suggests that sensitizing agents, which promote ligand expression or prevent shedding thereof by multiple mechanisms [70–73], may prove valuable as combination treatments acting in concert with other therapeutic approaches.”
BackgroundImmunotherapy in Acute Leukemia
Leung, W. H. (2008) · Seminars in Hematology · doi:10.1053/j.seminhematol.2008.09.004 · Cited by 11
Role natural killer group 2D-ligand interactions in hepatitis B infection
Pollicino, T., & Koumbi, L. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i6.819 · Cited by 10
Cascone, R., Carlucci, A., Pierdiluca, M., Santini, M., & Fiorelli, A. (2017) · Lung Cancer Targets and Therapy · doi:10.2147/lctt.s105623 · Cited by 10
“pathway, and it has been proposed to play a role in human tumor rejection.(21) The presence of NKG2DL on cells sur-”
Innate sensing of cancer's non-immunologic hallmarks
Seelige, R., Searles, S. C., & Bui, J. D. (2017) · Current Opinion in Immunology · doi:10.1016/j.coi.2017.09.005 · Cited by 10
“Classic studies showed that DNA damage sensed by ATM/ATR could induce NKG2D ligands, leading to NK cell activation [8].”
BackgroundNguyen, H. P. Q., Bae, W. K., Park, M. S., Chung, I., Nam, T., Jeong, J., Uong, T. N. T., Cho, D., Kim, S., & Yoon, M. (2023) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-023-03545-w · Cited by 10
Lu, J., Das, M., Kanji, S., Aggarwal, R., Joseph, M., Ray, A., Shapiro, C. L., Pompili, V. J., & Das, H. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.04.003 · Cited by 10
“It has been shown that genotoxic stress or inhibitors of DNA-replication could up-regulate the expression of NKG2D ligand through activation of ATM (ataxia telangiectasia mutated) and ATR (ATMand Rad3-related) protein kinase pathway in human fibroblast and in mouse tumor cell lines, which led to enhance cytotoxic lysi…”
Mechanical Stress Downregulates MHC Class I Expression on Human Cancer Cell Membrane
Rocca, R. L., Tallerico, R., Hassan, A. T., Das, G., Lakshmikanth, T., Matteucci, M., Liberale, C., Mesuraca, M., Scumaci, D., Gentile, F., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111758 · Cited by 10
“We have indeed analysed the effect of mechanical stress on ATM/ATR signalling cascade [41] and on the SAPK/JNK pathway [42].”
BackgroundVeneziani, I., Brandetti, E., Ognibene, M., Pezzolo, A., Pistoia, V., & Cifaldi, L. (2018) · Journal of Immunology Research · doi:10.1155/2018/4972410 · Cited by 10
“The genotoxic e ff ect typical of several anticancer agents induces DNA damage response (DDR), the pathway most extensively associated with the induction of the expression of ligands for NK cell-activating receptors [11 – 14].”
Hu, J., Xia, X., Zhao, Q., & Li, S. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.12.002 · Cited by 11
Myelodysplastic syndrome and immunotherapy novel to next in-line treatments
Linder, K. J., & Lulla, P. (2021) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2021.1898307 · Cited by 11
“Preclinical models have since demonstrated that cytotoxic chemotherapy upregulates NKG2D ligand expression, decreases Treg activity and thus enhances NKG2D CAR-T cell expansion.(62,68,72,73) This led to the DEPLETHINK phase 1 trial(74) for patients with relapsed/refractory AML or MDS where patients were treated with l…”
BackgroundReinardy, H. C., Chapman, J., & Bodnar, A. G. (2016) · Biology Letters · doi:10.1098/rsbl.2015.1057 · Cited by 10
“Other genes that responded to the genotoxicant treatment were TANKbinding kinase 1 (tbk1) and irf4, which are associated with DNA-PK in surveying DNA and signalling IRF3-dependent nuclear transcription [23], non-significant upregulation of rae1, an NKG2D ligand involved in protein binding [13], and a significant upreg…”
BackgroundBiassoni, R., Ugolotti, E., & Maria, A. D. (2010) · Self/Nonself · doi:10.4161/self.1.2.11717 · Cited by 10
Pinto, A. K., Jamieson, A. M., Raulet, D. H., & Hill, A. B. (2007) · Journal of Virology · doi:10.1128/jvi.01328-07 · Cited by 10
“duced by transformation or stress, notably by viral infection (1, 12).”
BackgroundSelf-citationNK Cells in Myeloproliferative Neoplasms (MPN)
Naismith, E., Steichen, J., Sopper, S., & Wolf, D. G. F. (2021) · Cancers · doi:10.3390/cancers13174400 · Cited by 9
“aNKR ligands can also be upregulated by cellular stress or as a response to DNA damage, both of which are common in many different types of cancer [45].”
BackgroundRobo1 CAR-NK92 and radiotherapy exert synergistic efficacy in solid tumors
Wu, M., He, J., Geng, J., Wei, Z., Cheng, R., Li, H., & Xing, L. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06753-3 · Cited by 9
Omidvar, S., Vahedian, V., Sourani, Z., Yari, D., Asadi, M., Jafari, N., Khodavirdilou, L., Bagherieh, M., Shirzad, M., & Hosseini, V. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155405 · Cited by 9
A novel facet of tumor suppression by p53: Induction of tumor immunogenicity
Li, H., Lakshmikanth, T., Carbone, E., & Selivanova, G. (2012) · OncoImmunology · doi:10.4161/onci.19409 · Cited by 11
Høgh, R. I., Droujinine, A., Møller, S. H., Jepsen, S. D., Mellergaard, M., Andresen, L. O., & Skov, S. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1900740 · Cited by 10
The Activating Receptors of Natural Killer Cells and Their Inter-Switching Potentials
Rowaiye, A. B., Asala, T., Oli, A. N., Uzochukwu, I. C., Akpa, A., & Esimone, C. O. (2020) · Current Drug Targets · doi:10.2174/1389450121666200910160929 · Cited by 9
Okita, R., Shimizu, K., Nojima, Y., Saisho, S., & Nakata, M. (2021) · Thoracic Cancer · doi:10.1111/1759-7714.13847 · Cited by 10
Sato, Y., Mori, K., Hirano, K., Yagi, K., Kobayashi, Y., Nagaoka, K., Hosoi, A., Matsushita, H., Kakimi, K., & Seto, Y. (2021) · Cytotherapy · doi:10.1016/j.jcyt.2021.02.002 · Cited by 9
Grewal, R. K., & Das, J. (2022) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1010114 · Cited by 9
“[63] observed aphidicolin treatment moderately increases the expression of NKG2D ligands in mouse T-cell blast target cells and these target cells showed increased lysis compared to their untreated counterparts.”
BackgroundAgeing impairs protective immunity and promotes susceptibility to murine visceral leishmaniasis
Salgado, C. L., Corea, A. F. M., Covre, L. P., Guedes, H. L. D. M., Falqueto, A., & Gomes, D. C. O. (2022) · Parasitology · doi:10.1017/s0031182022000828 · Cited by 10
“These can directly modulate the expression of stress ligands, including inhibitory receptors and ligands by immune and nonimmune cells (Groh et al., 2001; Gasser et al., 2005).”
BackgroundChemotherapy: A partnership with immunotherapy in n on‐small cell lung cancer
Mendes, A. S., Romão, R., Febra, J., Azevedo, S. X., Fidalgo, P., & Araújo, A. (2022) · Thoracic Cancer · doi:10.1111/1759-7714.14779 · Cited by 9
“Compounds derived from platinum stimulate the expression of natural killer group 2D (NKG2D) ligand, a NK-cell activating receptor, resulting in an increased NK-cell cytotoxicity and production of interferon-γ (IFN-γ).(16) Consequently, CT affects the phenotype of malignant cells that survive antineoplastic treatments,…”
BackgroundKoh, E.-K., Lee, H.-R., Son, W.-C., Park, G., Bae, J., & Park, Y.-S. (2023) · Oncology Letters · doi:10.3892/ol.2023.13818 · Cited by 9
Lieberman, R., Pan, J., Zhang, Q., & You, M. (2017) · Oncotarget · doi:10.18632/oncotarget.16371 · Cited by 9
“One of the most representative links between innate immunity and DDR is the activation of natural killer group 2 (NKG2D) in DNA-damaged cells by ataxia telangiectasia mutation (ATM), which alerts and recruits NK cells at the injured site [27].”
BackgroundLorenzo‐Herrero, S., Sordo‐Bahamonde, C., Gonzalez, S. R., & López‐Soto, A. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8885-3_8 · Cited by 9
Immune Surveillance from Chromosomal Chaos?
Zanetti, M., & Mahadevan, N. R. (2012) · Science · doi:10.1126/science.1228464 · Cited by 9
Transactions on micronuclear DNA and implications for immune signaling
Maciejowski, J., & Greenberg, R. A. (2025) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2025.10.007 · Cited by 9
Natural killer cell immunotherapy reverses lung fibrosis by eliminating senescent fibroblasts
Merkt, W., Rodon, L., Deicher, F. S., Freitag, M., Claus, M., Lister, R. T., Han, H., Zhou, Y., Horne, A., Stütz, A. N., et al. (2026) · Science Translational Medicine · doi:10.1126/scitranslmed.adq5442 · Cited by 11
Emerging role of immunotherapy in urothelial carcinoma—Future directions and novel therapies
Park, J., & Hahn, N. M. (2016) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2016.09.002 · Cited by 8
von Linsingen, R., de França, P. P., de Carvalho, N. S., & Bicalho, M. D. G. (2020) · Human Immunology · doi:10.1016/j.humimm.2020.02.007 · Cited by 8
Shatnyeva, O., Hansen, H. P., Reiners, K. S., Sauer, M., Vyas, M., & von Strandmann, E. P. (2015) · Frontiers in Genetics · doi:10.3389/fgene.2015.00011 · Cited by 9
“The expression of NKG2D ligands in response to genotoxic stress and stalled DNA replication forks is induced through canonical DDR in an ATM/ATR-dependent fashion in mouse and human fibroblasts (Gasser et al., 2005).”
BackgroundATM activation mediates anticancer immunosurveillance by natural killer and T cells
Tang, M. L., & Gasser, S. (2013) · OncoImmunology · doi:10.4161/onci.24438 · Cited by 9
“Importantly, p53 is dispensable for the induction of murine NKG2D and DNAM-1 ligands in response to DNA damage.(4) A report by Xue et al.”
BackgroundSelf-citationSmits, N. C., Coupet, T. A., Godbersen, C., & Sentman, C. L. (2016) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2016.1195364 · Cited by 10
Upregulation of NKG2D ligands impairs hematopoietic stem cell function in Fanconi anemia
Casado, J. A., Valeri, A., Sánchez‐Domínguez, R., Vela, P., López, A., Navarro, S., Alberquilla, O., Hanenberg, H., Pujol, R. M., Segovia, J. C., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci142842 · Cited by 8
“cells could be recognized by cells of the immune system (25, 27, 30, 31), we hypothesized that FA cells could be prone to overexpress NKG2D-Ls, and also that this upregulation on FA HSCs could play a relevant role in the etiology of BMF progression in patients with FA.”
BackgroundPromoting T and NK cell attack: preserving tumor MICA/B by vaccines
Cichocki, F. M., & Miller, J. S. (2022) · Cell Research · doi:10.1038/s41422-022-00696-w · Cited by 8
Antitumor Immunity Exerted by Natural Killer and Natural Killer T Cells in the Liver
Nakashima, H., & Kinoshita, M. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12030866 · Cited by 8
“Moreover, NKG2D expression is up-regulated by various kinds of cellular stresses [6], such as heat shock [7] and DNA damage-related antigens [8].”
BackgroundLi, G., Nikkhoi, S. K., & Hatefi, A. (2023) · Medical Oncology · doi:10.1007/s12032-023-01975-1 · Cited by 8
“In addition to killing cancer cells directly at micromolar levels, 5-FU has been shown to increase NKG2D ligands expression via ataxia telangiectasia mutated (ATM)- and Rad3-related (ATR) protein kinases pathways [13, 38].”
BackgroundTong, H. V., Song, L. H., Hoan, N. X., Cuong, B. K., Sỹ, B. T., Sơn, H. A., Đỗ, Q., Binh, V. Q., Kremsner, P. G., Bock, C. –., et al. (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-0754-x · Cited by 8
“This hypothesis is supported by several studies which demonstrate that MICB was not only expressed in tumor cells but also in different non-tumor cell lines under stress conditions [27,28,39,40].”
ResultDulaimi, D. A., Klibi, J., Pimentel, V. O., Parietti, V., Allez, M., Toubert, A., & Benlagha, K. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01052 · Cited by 8
“The ligands of NKG2D are known to be “stress-inducible” molecules, induced by cellular transformation, viral infection (20), and/or DNA damage (21).”
BackgroundExpression of LY 6 D is induced at the surface of MCF10A cells by X ‐ray irradiation
Kurosawa, M., Jeyasekharan, A. D. D., Surmann, E., Hashimoto, N., Venkatraman, V., Kurosawa, G., Furukawa, K., Venkitaraman, A. R., & Kurosawa, Y. (2012) · FEBS Journal · doi:10.1111/febs.12034 · Cited by 8
Correction: Cellular Expression, Trafficking, and Function of Two Isoforms of Human ULBP5/RAET1G
Eagle, R. A., Flack, G., Warford, A., Martínez-Borra, J., Jafferji, I., Traherne, J. A., Ohashi, M., Boyle, L. H., Barrow, A. D., Caillat‐Zucman, S., et al. (2009) · PLoS ONE · doi:10.1371/annotation/34238ee8-5128-4f1d-9ae2-6906c9764e49 · Cited by 8
Synthetic NKG2D receptor (SNR) armored CAR-T cells overcome antigen heterogeneity of solid tumor
Sun, M., Bian, L., Wang, H., Liu, X., Li, Y., Wu, Z., Zhang, S., Hao, R., Xin, H., Zhai, B., et al. (2025) · Cellular Oncology · doi:10.1007/s13402-025-01066-5 · Cited by 7
Huang, M., Wang, S., Huang, H., Li, L., & Wang, T. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1705354 · Cited by 7
Rewiring melanoma cell fate: TRPM8 modulators trigger apoptosis and boost NK cell cytotoxicity
Sorrentino, C., Lauretta, C., D’Angiolo, R., Musella, S., Giovannelli, P., Bertamino, A., Ostacolo, C., Monterrey, I. G., Migliaccio, A., Castoria, G., et al. (2026) · Cell Death and Disease · doi:10.1038/s41419-026-08469-8 · Cited by 7
“Furthermore, p53 has been shown to bind directly to the ULBP1 and ULBP2 loci, suggesting that it can act as a transcriptional ampli fi er under stress conditions [36, 37].”
InfluentialHLA-E single-chain trimer shields gene-edited allogeneic CAR T cells from NK cell attack
Apodaca, K., Xu, C., Stanton, K. L., Baroja, M. L., Doblado, A. R. A., Engel, N., Wellhausen, N., Cox, A. C., Berjis, A., Ji, M., et al. (2026) · Blood Advances · doi:10.1182/bloodadvances.2025016927 · Cited by 7
“33 ,34 LFA-1 has been shown to function as an important adhesion molecule, interacting with CD54 early in immune synapse formation during NK cell lytic activation.”
The inhibitory NKR-P1B receptor regulates NK cell-mediated mammary tumor immunosurveillance in mice
Olabi, R. A., Hendy, A. E. A., Alkassab, M. B., Alnajm, K., Elias, M., Ibrahim, M., Carlyle, J. R., Makrigiannis, A. P., & Rahim, M. M. A. (2023) · OncoImmunology · doi:10.1080/2162402x.2023.2168233 · Cited by 7
“Known ligands for activating receptors include viral proteins, such as m157 and m12 proteins of the mouse cytomegalovirus (MCMV)(12,13) and self-MHC-like proteins, such as MICA and MICB in humans(14) and Rae1 in mice,(15) which are upregulated in cells undergoing neoplastic transformation and genotoxic stress.(16) The…”
BackgroundTumor suppressors control ULBP2, an innate surface ligand of the lymphocyte immune receptor NKG2D
Heinemann, A., & Paschen, A. (2012) · OncoImmunology · doi:10.4161/onci.19406 · Cited by 7
“demonstrated that genotoxic agents induce NKG2D ligand (NKG2DL) expression in murine and human cells.(2) Based on this observation, the model of NKG2DL as an innate barrier against tumor development emerged which led us to ask for the role of tumor suppressors in the regulation of their expression.”
Damage control: how HIV survives the editor APOBEC3G
Croxford, J. L., & Gasser, S. (2011) · Nature Immunology · doi:10.1038/ni.2115 · Cited by 7
Self-citationDemel, I., Kořístek, Z., Motais, B., Hájek, R., & Jelínek, T. (2022) · American Journal of Hematology · doi:10.1002/ajh.26529 · Cited by 7
Campos‐Silva, C., López-Borrego, S., Felgueres, M. J., Esteso, G., & Valés‐Gómez, M. (2022) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2022045263 · Cited by 8
Pesini, C., Artal, L., Bernal, J. P., Sánchez‐Martínez, D., Pardo, J., & Ramírez-Labrada, A. (2024) · OncoImmunology · doi:10.1080/2162402x.2024.2379062 · Cited by 8
Mapping the biogenesis of forward programmed megakaryocytes from induced pluripotent stem cells
Lawrence, M., Shahsavari, A., Bornelöv, S., Moreau, T., McDonald, R., Vallance, T. M., Kania, K., Paramor, M., Baye, J., Perrin, M., et al. (2022) · Science Advances · doi:10.1126/sciadv.abj8618 · Cited by 7
Stratégies d’immunothérapie dans les cancers colorectaux
Tougeron, D., Fauquembergue, É., & Latouche, J. (2013) · Bulletin du Cancer · doi:10.1684/bdc.2013.1800 · Cited by 8
Metadata
- Authors
- Gasser, S., Orsulic, S., Brown, E. J., & Raulet, D. H.
- Affiliations
- University of California, Berkeley (US)
- University of Pennsylvania (US)
- Corresponding author
- Raulet, David H.
- Venue
- Nature
- Published
- 2005-07-03
- Volume
- 436
- Issue
- 7054
- Pages
- 1186-1190
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC1352168
- OpenAlex
- W1969464492
- Cited by
- 1,308
- References
- 28
- Citations by year
- 2026: 23 · 2025: 39 · 2024: 26 · 2023: 51 · 2022: 57 · 2021: 60 · 2020: 72 · 2019: 62 · 2018: 62 · 2017: 64 · 2016: 63 · 2015: 71 · 2014: 85 · 2013: 74 · 2012: 68
- FWCI
- 28.11
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Prostate Cancer Foundation
- National Institutes of Health
- National Cancer Institute (R01CA093678)
- National Institute of Allergy and Infectious Diseases (R01AI039642)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Keywords
- NKG2D, NKG2D ligands, DNA damage response, innate immunity, ATM kinase, ATR kinase, Chk1, genotoxic stress, natural killer cells, CD8+ T cells, cancer cell lines, siRNA
- MeSH terms
- Checkpoint Kinase 1, Animals, Cell Transformation, Neoplastic, DNA Damage, DNA Replication, Fibroblasts, Humans, Immune System, Immunity, Innate, Kinetics, Ligands, Mice, Inbred C57BL, Phosphorylation, Protein Kinases, Receptors, Immunologic, Up-Regulation, Aphidicolin, Protein Serine-Threonine Kinases, Cell Cycle Proteins, Cell Line, Tumor, Mice, Receptors, Natural Killer Cell, NK Cell Lectin-Like Receptor Subfamily K, Ataxia Telangiectasia Mutated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.